Healthpeak Properties director Brinker buys $49,985 in stock

Published 31/07/2025, 19:02
Healthpeak Properties director Brinker buys $49,985 in stock

Healthpeak Properties (NYSE:DOC), Inc. NASDAQ:DOC Director Scott M. Brinker reported purchasing 2,930 shares of the company’s common stock on July 31, 2025. The shares were bought at a price of $17.06, for a total transaction value of $49,985. The purchase comes as the stock trades near its 52-week low of $16.64, with InvestingPro analysis suggesting the stock is currently undervalued.

Following the transaction, Brinker directly owns 210,416 shares of Healthpeak Properties. The company offers an attractive 7.08% dividend yield and has maintained dividend payments for 41 consecutive years. For deeper insights into Healthpeak Properties’ valuation and 8 additional key metrics, check out the comprehensive Pro Research Report available on InvestingPro.

In other recent news, Healthpeak Properties reported its second-quarter 2025 earnings, revealing mixed results. The company’s earnings per share (EPS) were $0.05, falling short of the anticipated $0.064, a miss of approximately 21.88%. On a positive note, Healthpeak’s revenue slightly exceeded expectations, coming in at $694.35 million compared to the forecasted $689.32 million. Despite the revenue beat, investor concerns were evident following the earnings miss. Scotiabank (TSX:BNS) downgraded Healthpeak Properties from Sector Outperform to Sector Perform, citing weak leasing performance and rising laboratory credit risk concerns. Additionally, Scotiabank adjusted its price target for the company to $19.00. Meanwhile, KeyBanc reiterated its Sector Weight rating for Healthpeak Properties, highlighting ongoing lab occupancy issues impacting the healthcare REIT’s performance. These developments reflect a challenging period for Healthpeak Properties amid broader market dynamics.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.